Balyasny Asset Management
ZBH icon

Balyasny Asset Management’s Zimmer Biomet ZBH Stock Holding History

Balyasny Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-51,500
Closed -$5.67M – 1102
2014
Q4 		$5.67M Buy
+51,500
New +$5.43M 0.05% 407

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's ZBH Position: Q1 2026 in Review

Balyasny Asset Management increased its Zimmer Biomet (ZBH) stake by 12,817% in Q1 2026, buying an estimated $38.7M and bringing the position to 424,578 shares worth $38.4M. The position accounts for 0.05% of the portfolio, ranked #427.

Balyasny Asset Management first reported a position in ZBH in Q3 2013 and has held it in 40 quarters since. The position peaked at $124M in Q3 2022. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Balyasny Asset Management held 424,578 shares of Zimmer Biomet worth $38.4M as of Q1 2026.
  • Balyasny Asset Management bought 421,291 Zimmer Biomet shares in Q1 2026, an estimated $38.7M.
  • Zimmer Biomet made up 0.05% of Balyasny Asset Management's portfolio in Q1 2026, its #427 holding.
  • Balyasny Asset Management first reported a position in Zimmer Biomet in Q3 2013 and has held it in 40 quarters since.
  • Balyasny Asset Management's Zimmer Biomet position peaked at $124M in Q3 2022.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.